Skip to main content

Table1 Summarized patient’s clinical information and diagnosis parameters

From: The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistance

No

Age

Initial PSA (ng/mL)

TPSA (ng/mL)

F/U, time-Mo

Metastasis

Treatment

Evaluation

Bx interval-Mo

Orchie-ctomy

HT

Chemo-Tx

Initial-T

Post-T

Pt.1

68

 > 100

180

30

lymph node

 

Yes

 

V

R

27

Pt.2

65

 > 1000

600

14

bone

 

Yes

Yes

V

R

18

Pt.3

69

 < 100

118.3

10

bone

Yes

Yes

Yes

V

R

20

Pt.4

72

 > 100

NA

24

bone

 

Yes

Yes

V

R

20

Pt.5

65

 > 100

149

7

bone

 

Yes

 

V

R

7

  1. Pt patient, F/U Follow up, Mo months, HT hormone therapy, V valid, R resistance, Bx biopsy, NA not applicable